Marker Therapeutics Inc (NASDAQ:MRKR)
| 3.23 Delayed Data As of Dec 08 |  +0.405 / +14.36%Today’s Change | 0.67 Today|||52-Week Range 9.68 | +21.29% Year-to-Date |
Latest MRKR News | Press Releases
No recent news for Marker Therapeutics Inc.
Today’s Trading
| Previous close | 2.82 |
| Today’s open | 2.94 |
| Day’s range | 2.88 - 3.23 |
| Volume | 1,061 |
| Average volume (3 months) | 43,186 |
| Market cap | $24.5M |
Data as of 3:48pm ET, 12/08/2023
Growth & Valuation
| Earnings growth (last year) | +34.53% |
| Earnings growth (this year) | +5.03% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +342.94% |
| P/E ratio | NM |
| Price/Sales | 4.04 |
| Price/Book | 1.17 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| RDHLRedhill Biopharma Lt... | -0.01 | -0.78% |
| ---- | ||
| ABIOARCA Biopharma Inc | -0.01 | -0.72% |
| PPBTPurple Biotech Ltd | +0.06 | +5.56% |
Data as of 3:59pm ET, 12/08/2023
Financials
| Next reporting date | March 21, 2024 |
| EPS forecast (this quarter) | -$0.90 |
| Annual revenue (last year) | $5.5M |
| Annual profit (last year) | -$29.9M |
| Net profit margin | -544.19% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Houston, Texas |
Forecasts
